Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRFM for Hair Density in Alopecia
NCT01590238Phase 3Completed
- Sponsor
- New York Eye and Ear Infirmary of Mount Sinai
- Start
- May 2012
- Primary completion
- Sep 2013
- Modality
- Hydrogel Systems, Recombinant Proteins and Enzymes, Device-based Delivery
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of platelet-rich fibrin matrix in alopecia, sponsored by New York Eye and Ear Infirmary of Mount Sinai. Primary endpoint: Hair Density Change After Three Treatments at 6 months. Started May 2012; status: completed.
02
Drugs
platelet-rich fibrin matrix
03
Conditions
alopecia
Beyond the preview
Go deeper on NCT01590238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01590238.